Am J Surg Pathol

1. MARK E, Kempf W, Guitart J, Pulitzer M, et al
   Lymphomatoid Papulosis With T-cell Receptor-Gamma Delta Expression: A Clinicopathologic Case-series of 26 Patients of an Underrecognized Immunophenotypic Variant of Lymphomatoid Papulosis.
   Am J Surg Pathol. 2024;48:501-510.
   

   >> Share

   
   

   
   Am Surg

2. SYMEONIDIS NG, Stavrati KE, Pavlidis ET, Psarras KK, et al
   B-Lymphoblastic Lymphoma of the Small Bowel: An Extremely Rare Occurrence.
   Am Surg. 2023;89:1280-1282.
   

   >> Share

   
   

   
   Blood

3. LOCKE FL, Siddiqi T, Jacobson CA, Ghobadi A, et al
   Real-World and Clinical Trial Outcomes in Large B-cell Lymphoma with Axicabtagene Ciloleucel Across Race and Ethnicity.
   Blood. 2024 Apr 18:blood.2023023447. doi: 10.1182/blood.2023023447.
   

   >> Share

   
   
4. SUREDA-GOMEZ M, Iaccarino I, De Bolos A, Meyer MA, et al
   SOX11 expression is restricted to EBV-negative Burkitt lymphoma and associates with molecular genetic features.
   Blood. 2024 Apr 15:blood.2023023242. doi: 10.1182/blood.2023023242.
   

   >> Share

   
   

   
   Bone Marrow Transplant

5. DONADEL CD, De Santis GC, Goncalves TE, Pires BG, et al
   Safety and efficacy of a new academic CD19-directed CAR-T cell for refractory/relapsed non-Hodgkin lymphoma and acute lymphoblastic leukemia in Brazil.
   Bone Marrow Transplant. 2024 Apr 13. doi: 10.1038/s41409-024-02283.
   

   >> Share

   
   

   
   Br J Haematol

6. LEWIS CS, Joy G, Jensen P, Barraclough A, et al
   Primary gastric diffuse large B-cell lymphoma: A multicentre retrospective study.
   Br J Haematol. 2024 Apr 17. doi: 10.1111/bjh.19470.
   

   >> Share

   
   
7. CAO XY, Zhang JP, Lu Y, Zhao YL, et al
   A safety and efficacy study of allogeneic haematopoietic stem cell transplantation for refractory and relapsed T-cell acute lymphoblastic leukaemia/lymphoblastic lymphoma patients who achieved complete remission after autologous CD7 chimeric antigen r
   Br J Haematol. 2024 Apr 13. doi: 10.1111/bjh.19445.
   

   >> Share

   
   
8. GANAPATHI KA, Nicolae A, Egan C, Geng H, et al
   Peripheral T-cell lymphomas expressing CD30 and CD15 expand the spectrum of anaplastic large cell lymphoma, ALK-negative.
   Br J Haematol. 2024 Apr 12. doi: 10.1111/bjh.19442.
   

   >> Share

   
   

   
   Cancer Lett

9. LIANG JH, Wang WT, Wang R, Gao R, et al
   PRMT5 activates lipid metabolic reprogramming via MYC contributing to the growth and survival of mantle cell lymphoma.
   Cancer Lett. 2024;591:216877.
   

   >> Share

   
   

   
   Cancer Res

10. XU X, Zhang Y, Lu Y, Zhang X, et al
    CD58 alterations govern antitumor immune responses by inducing PD-L1 and IDO in diffuse large B-cell lymphoma.
    Cancer Res. 2024 Apr 18. doi: 10.1158/0008-5472.CAN-23-2874.
    

    >> Share

    
    

    
    Eur J Haematol

11. RICHARDSON T, Scheid C, Herling M, Frenzel LP, et al
    Post-transplant-cyclophosphamide and short-term Everolimus as graft-versus-host-prophylaxis in patients with relapsed/refractory lymphoma and myeloma-Final results of the phase II OCTET-EVER trial.
    Eur J Haematol. 2024 Apr 14. doi: 10.1111/ejh.14210.
    

    >> Share

    
    

    
    Haematologica

12. CAIRO MS
    TP3 binding domain mutations are bad news in Burkitt lymphoma.
    Haematologica. 2024 Apr 18. doi: 10.3324/haematol.2024.285213.
    

    >> Share

    
    

    
    Int J Radiat Oncol Biol Phys

13. ROSENBROCK J, Kaul H, Oertel M, Celik E, et al
    Involved-site radiotherapy is equally effective and less toxic than Involved-field radiotherapy in patients receiving combined modality treatment for early-stage unfavorable Hodgkin lymphoma - an analysis of the randomized phase III HD17 trial of the
    Int J Radiat Oncol Biol Phys. 2024 Apr 15:S0360-3016(24)00514.
    

    >> Share

    
    

    
    J Clin Oncol

14. YAN C, Richard MA, Gibson CJ, He J, et al
    Clonal Hematopoiesis and Therapy-Related Myeloid Neoplasms After Autologous Transplant for Hodgkin Lymphoma.
    J Clin Oncol. 2024 Apr 18:JCO2302547. doi: 10.1200/JCO.23.02547.
    

    >> Share

    
    

    
    Leuk Lymphoma

15. ALZAHRANI M, Villa D
    Management of relapsed/refractory mantle cell lymphoma.
    Leuk Lymphoma. 2024 Apr 18:1-11. doi: 10.1080/10428194.2024.2338851.
    

    >> Share

    
    
16. TA A, Kaur S, Mader M, Franklin K, et al
    The impact of race and ethnicity on diffuse large B-cell lymphoma outcomes within the veterans health administration (VHA).
    Leuk Lymphoma. 2024 Apr 15:1-10. doi: 10.1080/10428194.2024.2338856.
    

    >> Share

    
    

    
    PLoS One

17. GORRES KL, Reineke DM, Miller G
    Transcriptome analysis of Burkitt lymphoma cells treated with anti-convulsant drugs that are inhibitors of Epstein-Barr virus lytic reactivation.
    PLoS One. 2024;19:e0299198.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share